We had a 2 ½ hour hearing on medical cannabis legislation this afternoon.

I asked one question: How does the directive from Attorney General Sessions regarding federal prosecutions of marijuana offenses affect Maryland’s program?

“We are already studying that question and will share our conclusions with you and the committee,” responded an Assistant Maryland Attorney General.

I also emailed our committee counsel to ask how this year’s bill differs from the legislation that passed the House last year.

Several witnesses asked us to change the law to increase their chance of being awarded a license.

It’s our job to balance making this treatment option available to those who need it in a medically appropriate manner with achieving diversity of ownership within the industry.

But I must admit. I was partial to the testimony of the witnesses from Hippocratic Growth.

Any group that imaginative in naming itself must know what it’s doing.